nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCG2—lung cancer	0.227	0.706	CbGaD
Pantoprazole—ABCB1—lung cancer	0.0944	0.294	CbGaD
Pantoprazole—ABCG2—Topotecan—lung cancer	0.0345	0.0752	CbGbCtD
Pantoprazole—ABCG2—Gefitinib—lung cancer	0.0315	0.0688	CbGbCtD
Pantoprazole—ABCG2—Teniposide—lung cancer	0.0306	0.0667	CbGbCtD
Pantoprazole—SLCO1B1—Irinotecan—lung cancer	0.0212	0.0462	CbGbCtD
Pantoprazole—ABCG2—Erlotinib—lung cancer	0.0186	0.0407	CbGbCtD
Pantoprazole—ABCG2—Paclitaxel—lung cancer	0.0171	0.0372	CbGbCtD
Pantoprazole—ABCG2—Irinotecan—lung cancer	0.0168	0.0367	CbGbCtD
Pantoprazole—CYP2C19—Gefitinib—lung cancer	0.0141	0.0307	CbGbCtD
Pantoprazole—ABCG2—Cisplatin—lung cancer	0.0137	0.0299	CbGbCtD
Pantoprazole—CYP2C19—Teniposide—lung cancer	0.0137	0.0298	CbGbCtD
Pantoprazole—ABCG2—Etoposide—lung cancer	0.0135	0.0294	CbGbCtD
Pantoprazole—ABCB1—Topotecan—lung cancer	0.0124	0.0271	CbGbCtD
Pantoprazole—ABCG2—Docetaxel—lung cancer	0.0123	0.0269	CbGbCtD
Pantoprazole—CYP2C9—Gefitinib—lung cancer	0.0117	0.0255	CbGbCtD
Pantoprazole—ABCB1—Gefitinib—lung cancer	0.0114	0.0248	CbGbCtD
Pantoprazole—CYP2C9—Teniposide—lung cancer	0.0114	0.0248	CbGbCtD
Pantoprazole—SLCO1B1—Methotrexate—lung cancer	0.0112	0.0245	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—lung cancer	0.00919	0.0201	CbGbCtD
Pantoprazole—ABCG2—Methotrexate—lung cancer	0.00891	0.0194	CbGbCtD
Pantoprazole—ABCB1—Vinorelbine—lung cancer	0.00875	0.0191	CbGbCtD
Pantoprazole—CYP1A2—Erlotinib—lung cancer	0.00768	0.0168	CbGbCtD
Pantoprazole—CYP3A4—Topotecan—lung cancer	0.00745	0.0162	CbGbCtD
Pantoprazole—ABCB1—Crizotinib—lung cancer	0.00697	0.0152	CbGbCtD
Pantoprazole—CYP3A4—Gefitinib—lung cancer	0.00681	0.0149	CbGbCtD
Pantoprazole—ABCB1—Gemcitabine—lung cancer	0.00681	0.0149	CbGbCtD
Pantoprazole—ABCB1—Erlotinib—lung cancer	0.00672	0.0147	CbGbCtD
Pantoprazole—CYP3A4—Teniposide—lung cancer	0.0066	0.0144	CbGbCtD
Pantoprazole—CYP2C9—Paclitaxel—lung cancer	0.00634	0.0138	CbGbCtD
Pantoprazole—ABCB1—Paclitaxel—lung cancer	0.00615	0.0134	CbGbCtD
Pantoprazole—ABCB1—Irinotecan—lung cancer	0.00607	0.0132	CbGbCtD
Pantoprazole—CYP1A2—Etoposide—lung cancer	0.00556	0.0121	CbGbCtD
Pantoprazole—ABCB1—Vinblastine—lung cancer	0.0054	0.0118	CbGbCtD
Pantoprazole—CYP3A4—Vinorelbine—lung cancer	0.00525	0.0114	CbGbCtD
Pantoprazole—CYP2C9—Cisplatin—lung cancer	0.0051	0.0111	CbGbCtD
Pantoprazole—ABCB1—Cisplatin—lung cancer	0.00495	0.0108	CbGbCtD
Pantoprazole—ABCB1—Etoposide—lung cancer	0.00486	0.0106	CbGbCtD
Pantoprazole—ABCB1—Docetaxel—lung cancer	0.00445	0.0097	CbGbCtD
Pantoprazole—CYP3A4—Crizotinib—lung cancer	0.00417	0.0091	CbGbCtD
Pantoprazole—CYP3A4—Erlotinib—lung cancer	0.00403	0.00878	CbGbCtD
Pantoprazole—CYP3A4—Paclitaxel—lung cancer	0.00369	0.00804	CbGbCtD
Pantoprazole—CYP3A4—Irinotecan—lung cancer	0.00364	0.00793	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—lung cancer	0.00332	0.00723	CbGbCtD
Pantoprazole—CYP3A4—Vinblastine—lung cancer	0.00323	0.00705	CbGbCtD
Pantoprazole—ABCB1—Methotrexate—lung cancer	0.00321	0.00701	CbGbCtD
Pantoprazole—CYP3A4—Etoposide—lung cancer	0.00291	0.00635	CbGbCtD
Pantoprazole—CYP3A4—Docetaxel—lung cancer	0.00266	0.00581	CbGbCtD
Pantoprazole—CYP3A4—Doxorubicin—lung cancer	0.00199	0.00433	CbGbCtD
Pantoprazole—Omeprazole—ABCC3—lung cancer	0.00088	0.243	CrCbGaD
Pantoprazole—Rabeprazole—ABCG2—lung cancer	0.000524	0.145	CrCbGaD
Pantoprazole—Omeprazole—ABCG2—lung cancer	0.000427	0.118	CrCbGaD
Pantoprazole—Rabeprazole—CYP1A1—lung cancer	0.000411	0.114	CrCbGaD
Pantoprazole—Lansoprazole—ABCG2—lung cancer	0.000391	0.108	CrCbGaD
Pantoprazole—Omeprazole—CYP1A1—lung cancer	0.000335	0.0926	CrCbGaD
Pantoprazole—Lansoprazole—CYP1A1—lung cancer	0.000306	0.0847	CrCbGaD
Pantoprazole—Omeprazole—ABCB1—lung cancer	0.000178	0.0492	CrCbGaD
Pantoprazole—Lansoprazole—ABCB1—lung cancer	0.000163	0.045	CrCbGaD
Pantoprazole—Urinary tract disorder—Methotrexate—lung cancer	3.71e-05	0.000234	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Doxorubicin—lung cancer	3.71e-05	0.000234	CcSEcCtD
Pantoprazole—Anaphylactic shock—Docetaxel—lung cancer	3.71e-05	0.000234	CcSEcCtD
Pantoprazole—Oedema—Docetaxel—lung cancer	3.71e-05	0.000234	CcSEcCtD
Pantoprazole—Weight increased—Doxorubicin—lung cancer	3.7e-05	0.000233	CcSEcCtD
Pantoprazole—Pruritus—Gemcitabine—lung cancer	3.69e-05	0.000233	CcSEcCtD
Pantoprazole—Urethral disorder—Methotrexate—lung cancer	3.68e-05	0.000232	CcSEcCtD
Pantoprazole—Infection—Docetaxel—lung cancer	3.68e-05	0.000232	CcSEcCtD
Pantoprazole—Weight decreased—Doxorubicin—lung cancer	3.68e-05	0.000232	CcSEcCtD
Pantoprazole—Feeling abnormal—Etoposide—lung cancer	3.67e-05	0.000232	CcSEcCtD
Pantoprazole—Hyperglycaemia—Doxorubicin—lung cancer	3.67e-05	0.000231	CcSEcCtD
Pantoprazole—Diarrhoea—Irinotecan—lung cancer	3.67e-05	0.000231	CcSEcCtD
Pantoprazole—Pneumonia—Doxorubicin—lung cancer	3.65e-05	0.00023	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Etoposide—lung cancer	3.65e-05	0.00023	CcSEcCtD
Pantoprazole—Shock—Docetaxel—lung cancer	3.65e-05	0.00023	CcSEcCtD
Pantoprazole—Nervous system disorder—Docetaxel—lung cancer	3.63e-05	0.000229	CcSEcCtD
Pantoprazole—Thrombocytopenia—Docetaxel—lung cancer	3.63e-05	0.000229	CcSEcCtD
Pantoprazole—Infestation NOS—Doxorubicin—lung cancer	3.63e-05	0.000229	CcSEcCtD
Pantoprazole—Infestation—Doxorubicin—lung cancer	3.63e-05	0.000229	CcSEcCtD
Pantoprazole—Visual impairment—Methotrexate—lung cancer	3.62e-05	0.000229	CcSEcCtD
Pantoprazole—Tachycardia—Docetaxel—lung cancer	3.62e-05	0.000228	CcSEcCtD
Pantoprazole—Feeling abnormal—Paclitaxel—lung cancer	3.6e-05	0.000227	CcSEcCtD
Pantoprazole—Skin disorder—Docetaxel—lung cancer	3.6e-05	0.000227	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.59e-05	0.000227	CcSEcCtD
Pantoprazole—Hypersensitivity—Cisplatin—lung cancer	3.59e-05	0.000226	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Paclitaxel—lung cancer	3.57e-05	0.000225	CcSEcCtD
Pantoprazole—Diarrhoea—Gemcitabine—lung cancer	3.57e-05	0.000225	CcSEcCtD
Pantoprazole—Erythema multiforme—Methotrexate—lung cancer	3.55e-05	0.000224	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Doxorubicin—lung cancer	3.55e-05	0.000224	CcSEcCtD
Pantoprazole—Dizziness—Irinotecan—lung cancer	3.54e-05	0.000224	CcSEcCtD
Pantoprazole—Urticaria—Etoposide—lung cancer	3.54e-05	0.000223	CcSEcCtD
Pantoprazole—Jaundice—Doxorubicin—lung cancer	3.53e-05	0.000223	CcSEcCtD
Pantoprazole—Stomatitis—Doxorubicin—lung cancer	3.53e-05	0.000223	CcSEcCtD
Pantoprazole—Anorexia—Docetaxel—lung cancer	3.53e-05	0.000223	CcSEcCtD
Pantoprazole—Abdominal pain—Etoposide—lung cancer	3.52e-05	0.000222	CcSEcCtD
Pantoprazole—Body temperature increased—Etoposide—lung cancer	3.52e-05	0.000222	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—lung cancer	3.52e-05	0.000222	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—lung cancer	3.52e-05	0.000222	CcSEcCtD
Pantoprazole—Eye disorder—Methotrexate—lung cancer	3.51e-05	0.000222	CcSEcCtD
Pantoprazole—Tinnitus—Methotrexate—lung cancer	3.5e-05	0.000221	CcSEcCtD
Pantoprazole—Asthenia—Cisplatin—lung cancer	3.49e-05	0.00022	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—lung cancer	3.48e-05	0.000219	CcSEcCtD
Pantoprazole—Urticaria—Paclitaxel—lung cancer	3.47e-05	0.000219	CcSEcCtD
Pantoprazole—Hypotension—Docetaxel—lung cancer	3.46e-05	0.000218	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—lung cancer	3.46e-05	0.000218	CcSEcCtD
Pantoprazole—Body temperature increased—Paclitaxel—lung cancer	3.46e-05	0.000218	CcSEcCtD
Pantoprazole—Abdominal pain—Paclitaxel—lung cancer	3.46e-05	0.000218	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Doxorubicin—lung cancer	3.43e-05	0.000216	CcSEcCtD
Pantoprazole—Epistaxis—Doxorubicin—lung cancer	3.42e-05	0.000216	CcSEcCtD
Pantoprazole—Vomiting—Irinotecan—lung cancer	3.41e-05	0.000215	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—lung cancer	3.4e-05	0.000215	CcSEcCtD
Pantoprazole—Immune system disorder—Methotrexate—lung cancer	3.4e-05	0.000214	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—lung cancer	3.38e-05	0.000213	CcSEcCtD
Pantoprazole—Rash—Irinotecan—lung cancer	3.38e-05	0.000213	CcSEcCtD
Pantoprazole—Dermatitis—Irinotecan—lung cancer	3.38e-05	0.000213	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Docetaxel—lung cancer	3.38e-05	0.000213	CcSEcCtD
Pantoprazole—Chills—Methotrexate—lung cancer	3.37e-05	0.000213	CcSEcCtD
Pantoprazole—Headache—Irinotecan—lung cancer	3.36e-05	0.000212	CcSEcCtD
Pantoprazole—Insomnia—Docetaxel—lung cancer	3.35e-05	0.000211	CcSEcCtD
Pantoprazole—Diarrhoea—Cisplatin—lung cancer	3.33e-05	0.00021	CcSEcCtD
Pantoprazole—Paraesthesia—Docetaxel—lung cancer	3.33e-05	0.00021	CcSEcCtD
Pantoprazole—Alopecia—Methotrexate—lung cancer	3.32e-05	0.00021	CcSEcCtD
Pantoprazole—Vomiting—Gemcitabine—lung cancer	3.32e-05	0.000209	CcSEcCtD
Pantoprazole—Dyspnoea—Docetaxel—lung cancer	3.3e-05	0.000208	CcSEcCtD
Pantoprazole—Somnolence—Docetaxel—lung cancer	3.29e-05	0.000208	CcSEcCtD
Pantoprazole—Mental disorder—Methotrexate—lung cancer	3.29e-05	0.000208	CcSEcCtD
Pantoprazole—Rash—Gemcitabine—lung cancer	3.29e-05	0.000208	CcSEcCtD
Pantoprazole—Dermatitis—Gemcitabine—lung cancer	3.29e-05	0.000207	CcSEcCtD
Pantoprazole—Hypersensitivity—Etoposide—lung cancer	3.28e-05	0.000207	CcSEcCtD
Pantoprazole—Malnutrition—Methotrexate—lung cancer	3.27e-05	0.000206	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—lung cancer	3.27e-05	0.000206	CcSEcCtD
Pantoprazole—Headache—Gemcitabine—lung cancer	3.27e-05	0.000206	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—lung cancer	3.26e-05	0.000206	CcSEcCtD
Pantoprazole—Dyspepsia—Docetaxel—lung cancer	3.26e-05	0.000206	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—lung cancer	3.25e-05	0.000205	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—lung cancer	3.25e-05	0.000205	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—lung cancer	3.24e-05	0.000204	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—lung cancer	3.23e-05	0.000204	CcSEcCtD
Pantoprazole—Decreased appetite—Docetaxel—lung cancer	3.22e-05	0.000203	CcSEcCtD
Pantoprazole—Hypersensitivity—Paclitaxel—lung cancer	3.22e-05	0.000203	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—lung cancer	3.21e-05	0.000203	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—lung cancer	3.21e-05	0.000202	CcSEcCtD
Pantoprazole—Dysgeusia—Methotrexate—lung cancer	3.2e-05	0.000202	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Docetaxel—lung cancer	3.2e-05	0.000202	CcSEcCtD
Pantoprazole—Asthenia—Etoposide—lung cancer	3.2e-05	0.000202	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—lung cancer	3.2e-05	0.000202	CcSEcCtD
Pantoprazole—Fatigue—Docetaxel—lung cancer	3.19e-05	0.000202	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—lung cancer	3.19e-05	0.000201	CcSEcCtD
Pantoprazole—Nausea—Irinotecan—lung cancer	3.18e-05	0.000201	CcSEcCtD
Pantoprazole—Constipation—Docetaxel—lung cancer	3.17e-05	0.0002	CcSEcCtD
Pantoprazole—Pain—Docetaxel—lung cancer	3.17e-05	0.0002	CcSEcCtD
Pantoprazole—Back pain—Methotrexate—lung cancer	3.17e-05	0.0002	CcSEcCtD
Pantoprazole—Pruritus—Etoposide—lung cancer	3.15e-05	0.000199	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—lung cancer	3.14e-05	0.000198	CcSEcCtD
Pantoprazole—Asthenia—Paclitaxel—lung cancer	3.14e-05	0.000198	CcSEcCtD
Pantoprazole—Nausea—Gemcitabine—lung cancer	3.1e-05	0.000196	CcSEcCtD
Pantoprazole—Vomiting—Cisplatin—lung cancer	3.09e-05	0.000195	CcSEcCtD
Pantoprazole—Pruritus—Paclitaxel—lung cancer	3.09e-05	0.000195	CcSEcCtD
Pantoprazole—Vision blurred—Methotrexate—lung cancer	3.08e-05	0.000195	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—lung cancer	3.08e-05	0.000194	CcSEcCtD
Pantoprazole—Rash—Cisplatin—lung cancer	3.07e-05	0.000194	CcSEcCtD
Pantoprazole—Dermatitis—Cisplatin—lung cancer	3.07e-05	0.000193	CcSEcCtD
Pantoprazole—Feeling abnormal—Docetaxel—lung cancer	3.05e-05	0.000193	CcSEcCtD
Pantoprazole—Diarrhoea—Etoposide—lung cancer	3.05e-05	0.000192	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—lung cancer	3.04e-05	0.000192	CcSEcCtD
Pantoprazole—Ill-defined disorder—Methotrexate—lung cancer	3.04e-05	0.000192	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—lung cancer	3.03e-05	0.000191	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Docetaxel—lung cancer	3.03e-05	0.000191	CcSEcCtD
Pantoprazole—Anaemia—Methotrexate—lung cancer	3.02e-05	0.000191	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—lung cancer	3.02e-05	0.000191	CcSEcCtD
Pantoprazole—Diarrhoea—Paclitaxel—lung cancer	2.99e-05	0.000189	CcSEcCtD
Pantoprazole—Malaise—Methotrexate—lung cancer	2.95e-05	0.000186	CcSEcCtD
Pantoprazole—Dizziness—Etoposide—lung cancer	2.95e-05	0.000186	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—lung cancer	2.94e-05	0.000185	CcSEcCtD
Pantoprazole—Vertigo—Methotrexate—lung cancer	2.94e-05	0.000185	CcSEcCtD
Pantoprazole—Abdominal pain—Docetaxel—lung cancer	2.93e-05	0.000185	CcSEcCtD
Pantoprazole—Body temperature increased—Docetaxel—lung cancer	2.93e-05	0.000185	CcSEcCtD
Pantoprazole—Leukopenia—Methotrexate—lung cancer	2.93e-05	0.000185	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—lung cancer	2.92e-05	0.000184	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—lung cancer	2.91e-05	0.000183	CcSEcCtD
Pantoprazole—Dizziness—Paclitaxel—lung cancer	2.89e-05	0.000182	CcSEcCtD
Pantoprazole—Nausea—Cisplatin—lung cancer	2.89e-05	0.000182	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—lung cancer	2.88e-05	0.000181	CcSEcCtD
Pantoprazole—Cough—Methotrexate—lung cancer	2.86e-05	0.00018	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—lung cancer	2.85e-05	0.00018	CcSEcCtD
Pantoprazole—Convulsion—Methotrexate—lung cancer	2.84e-05	0.000179	CcSEcCtD
Pantoprazole—Vomiting—Etoposide—lung cancer	2.83e-05	0.000179	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—lung cancer	2.83e-05	0.000179	CcSEcCtD
Pantoprazole—Rash—Etoposide—lung cancer	2.81e-05	0.000177	CcSEcCtD
Pantoprazole—Dermatitis—Etoposide—lung cancer	2.81e-05	0.000177	CcSEcCtD
Pantoprazole—Headache—Etoposide—lung cancer	2.79e-05	0.000176	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—lung cancer	2.79e-05	0.000176	CcSEcCtD
Pantoprazole—Arthralgia—Methotrexate—lung cancer	2.79e-05	0.000176	CcSEcCtD
Pantoprazole—Chest pain—Methotrexate—lung cancer	2.79e-05	0.000176	CcSEcCtD
Pantoprazole—Myalgia—Methotrexate—lung cancer	2.79e-05	0.000176	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—lung cancer	2.78e-05	0.000175	CcSEcCtD
Pantoprazole—Vomiting—Paclitaxel—lung cancer	2.78e-05	0.000175	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—lung cancer	2.77e-05	0.000175	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.77e-05	0.000175	CcSEcCtD
Pantoprazole—Rash—Paclitaxel—lung cancer	2.76e-05	0.000174	CcSEcCtD
Pantoprazole—Dermatitis—Paclitaxel—lung cancer	2.75e-05	0.000174	CcSEcCtD
Pantoprazole—Discomfort—Methotrexate—lung cancer	2.75e-05	0.000174	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—lung cancer	2.75e-05	0.000174	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—lung cancer	2.74e-05	0.000173	CcSEcCtD
Pantoprazole—Headache—Paclitaxel—lung cancer	2.74e-05	0.000173	CcSEcCtD
Pantoprazole—Hypersensitivity—Docetaxel—lung cancer	2.73e-05	0.000172	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—lung cancer	2.72e-05	0.000172	CcSEcCtD
Pantoprazole—Confusional state—Methotrexate—lung cancer	2.69e-05	0.00017	CcSEcCtD
Pantoprazole—Anaphylactic shock—Methotrexate—lung cancer	2.67e-05	0.000168	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—lung cancer	2.67e-05	0.000168	CcSEcCtD
Pantoprazole—Asthenia—Docetaxel—lung cancer	2.66e-05	0.000168	CcSEcCtD
Pantoprazole—Infection—Methotrexate—lung cancer	2.65e-05	0.000167	CcSEcCtD
Pantoprazole—Nausea—Etoposide—lung cancer	2.65e-05	0.000167	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—lung cancer	2.63e-05	0.000166	CcSEcCtD
Pantoprazole—Pruritus—Docetaxel—lung cancer	2.62e-05	0.000165	CcSEcCtD
Pantoprazole—Nervous system disorder—Methotrexate—lung cancer	2.62e-05	0.000165	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—lung cancer	2.62e-05	0.000165	CcSEcCtD
Pantoprazole—Thrombocytopenia—Methotrexate—lung cancer	2.61e-05	0.000165	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—lung cancer	2.6e-05	0.000164	CcSEcCtD
Pantoprazole—Nausea—Paclitaxel—lung cancer	2.6e-05	0.000164	CcSEcCtD
Pantoprazole—Skin disorder—Methotrexate—lung cancer	2.59e-05	0.000164	CcSEcCtD
Pantoprazole—Hyperhidrosis—Methotrexate—lung cancer	2.58e-05	0.000163	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—lung cancer	2.56e-05	0.000161	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—lung cancer	2.55e-05	0.000161	CcSEcCtD
Pantoprazole—Anorexia—Methotrexate—lung cancer	2.55e-05	0.000161	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—lung cancer	2.54e-05	0.00016	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—lung cancer	2.54e-05	0.00016	CcSEcCtD
Pantoprazole—Diarrhoea—Docetaxel—lung cancer	2.54e-05	0.00016	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—lung cancer	2.5e-05	0.000158	CcSEcCtD
Pantoprazole—Hypotension—Methotrexate—lung cancer	2.5e-05	0.000157	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—lung cancer	2.49e-05	0.000157	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—lung cancer	2.47e-05	0.000156	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—lung cancer	2.45e-05	0.000155	CcSEcCtD
Pantoprazole—Dizziness—Docetaxel—lung cancer	2.45e-05	0.000155	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—lung cancer	2.45e-05	0.000154	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Methotrexate—lung cancer	2.43e-05	0.000153	CcSEcCtD
Pantoprazole—Insomnia—Methotrexate—lung cancer	2.42e-05	0.000152	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—lung cancer	2.41e-05	0.000152	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—lung cancer	2.41e-05	0.000152	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—lung cancer	2.41e-05	0.000152	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—lung cancer	2.4e-05	0.000152	CcSEcCtD
Pantoprazole—Paraesthesia—Methotrexate—lung cancer	2.4e-05	0.000151	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.4e-05	0.000151	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—lung cancer	2.38e-05	0.00015	CcSEcCtD
Pantoprazole—Dyspnoea—Methotrexate—lung cancer	2.38e-05	0.00015	CcSEcCtD
Pantoprazole—Somnolence—Methotrexate—lung cancer	2.37e-05	0.00015	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—lung cancer	2.36e-05	0.000149	CcSEcCtD
Pantoprazole—Vomiting—Docetaxel—lung cancer	2.36e-05	0.000149	CcSEcCtD
Pantoprazole—Dyspepsia—Methotrexate—lung cancer	2.35e-05	0.000148	CcSEcCtD
Pantoprazole—Rash—Docetaxel—lung cancer	2.34e-05	0.000147	CcSEcCtD
Pantoprazole—Dermatitis—Docetaxel—lung cancer	2.33e-05	0.000147	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—lung cancer	2.33e-05	0.000147	CcSEcCtD
Pantoprazole—Decreased appetite—Methotrexate—lung cancer	2.32e-05	0.000146	CcSEcCtD
Pantoprazole—Headache—Docetaxel—lung cancer	2.32e-05	0.000146	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—lung cancer	2.31e-05	0.000146	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—lung cancer	2.31e-05	0.000146	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Methotrexate—lung cancer	2.31e-05	0.000145	CcSEcCtD
Pantoprazole—Fatigue—Methotrexate—lung cancer	2.3e-05	0.000145	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—lung cancer	2.3e-05	0.000145	CcSEcCtD
Pantoprazole—Pain—Methotrexate—lung cancer	2.28e-05	0.000144	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—lung cancer	2.28e-05	0.000144	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—lung cancer	2.27e-05	0.000143	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—lung cancer	2.26e-05	0.000143	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—lung cancer	2.26e-05	0.000142	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—lung cancer	2.25e-05	0.000142	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—lung cancer	2.24e-05	0.000141	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—lung cancer	2.2e-05	0.000139	CcSEcCtD
Pantoprazole—Nausea—Docetaxel—lung cancer	2.2e-05	0.000139	CcSEcCtD
Pantoprazole—Feeling abnormal—Methotrexate—lung cancer	2.2e-05	0.000139	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Methotrexate—lung cancer	2.18e-05	0.000138	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—lung cancer	2.16e-05	0.000136	CcSEcCtD
Pantoprazole—Urticaria—Methotrexate—lung cancer	2.12e-05	0.000134	CcSEcCtD
Pantoprazole—Body temperature increased—Methotrexate—lung cancer	2.11e-05	0.000133	CcSEcCtD
Pantoprazole—Abdominal pain—Methotrexate—lung cancer	2.11e-05	0.000133	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.11e-05	0.000133	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—lung cancer	2.09e-05	0.000132	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—lung cancer	2.08e-05	0.000131	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—lung cancer	2.06e-05	0.00013	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—lung cancer	2.06e-05	0.00013	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—lung cancer	2.04e-05	0.000128	CcSEcCtD
Pantoprazole—Decreased appetite—Doxorubicin—lung cancer	2.01e-05	0.000127	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—lung cancer	2e-05	0.000126	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—lung cancer	1.99e-05	0.000126	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—lung cancer	1.98e-05	0.000125	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—lung cancer	1.98e-05	0.000125	CcSEcCtD
Pantoprazole—Hypersensitivity—Methotrexate—lung cancer	1.97e-05	0.000124	CcSEcCtD
Pantoprazole—Asthenia—Methotrexate—lung cancer	1.92e-05	0.000121	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—lung cancer	1.91e-05	0.00012	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—lung cancer	1.89e-05	0.000119	CcSEcCtD
Pantoprazole—Pruritus—Methotrexate—lung cancer	1.89e-05	0.000119	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—lung cancer	1.84e-05	0.000116	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—lung cancer	1.83e-05	0.000115	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—lung cancer	1.83e-05	0.000115	CcSEcCtD
Pantoprazole—Diarrhoea—Methotrexate—lung cancer	1.83e-05	0.000115	CcSEcCtD
Pantoprazole—Dizziness—Methotrexate—lung cancer	1.77e-05	0.000111	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—lung cancer	1.7e-05	0.000107	CcSEcCtD
Pantoprazole—Vomiting—Methotrexate—lung cancer	1.7e-05	0.000107	CcSEcCtD
Pantoprazole—Rash—Methotrexate—lung cancer	1.68e-05	0.000106	CcSEcCtD
Pantoprazole—Dermatitis—Methotrexate—lung cancer	1.68e-05	0.000106	CcSEcCtD
Pantoprazole—Headache—Methotrexate—lung cancer	1.67e-05	0.000106	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—lung cancer	1.66e-05	0.000105	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—lung cancer	1.64e-05	0.000103	CcSEcCtD
Pantoprazole—Nausea—Methotrexate—lung cancer	1.59e-05	0.0001	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—lung cancer	1.58e-05	9.98e-05	CcSEcCtD
Pantoprazole—Dizziness—Doxorubicin—lung cancer	1.53e-05	9.65e-05	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—lung cancer	1.47e-05	9.27e-05	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—lung cancer	1.46e-05	9.2e-05	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—lung cancer	1.46e-05	9.19e-05	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—lung cancer	1.45e-05	9.14e-05	CcSEcCtD
Pantoprazole—Nausea—Doxorubicin—lung cancer	1.37e-05	8.66e-05	CcSEcCtD
Pantoprazole—CYP3A4—Metabolism—MTMR3—lung cancer	7.13e-06	0.000123	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP1A1—lung cancer	7.06e-06	0.000122	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALDOA—lung cancer	7.03e-06	0.000121	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ERCC2—lung cancer	7e-06	0.000121	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTA4—lung cancer	7e-06	0.000121	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NCOA3—lung cancer	7e-06	0.000121	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	6.99e-06	0.00012	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PGAM1—lung cancer	6.94e-06	0.00012	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GNG11—lung cancer	6.9e-06	0.000119	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.88e-06	0.000118	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.87e-06	0.000118	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	6.84e-06	0.000118	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NCOA3—lung cancer	6.83e-06	0.000118	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTA2—lung cancer	6.82e-06	0.000117	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ADCY1—lung cancer	6.81e-06	0.000117	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ABCG2—lung cancer	6.81e-06	0.000117	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ENO2—lung cancer	6.67e-06	0.000115	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HPGDS—lung cancer	6.67e-06	0.000115	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ADCY1—lung cancer	6.64e-06	0.000114	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ABCG2—lung cancer	6.64e-06	0.000114	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPP2R1B—lung cancer	6.63e-06	0.000114	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2A7—lung cancer	6.62e-06	0.000114	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTA1—lung cancer	6.58e-06	0.000113	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALDOA—lung cancer	6.57e-06	0.000113	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.54e-06	0.000113	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—APOA1—lung cancer	6.54e-06	0.000113	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HPGDS—lung cancer	6.51e-06	0.000112	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ENO2—lung cancer	6.51e-06	0.000112	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCC3—lung cancer	6.51e-06	0.000112	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SDC4—lung cancer	6.48e-06	0.000112	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPP2R1B—lung cancer	6.47e-06	0.000112	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTT1—lung cancer	6.47e-06	0.000112	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP2A6—lung cancer	6.4e-06	0.00011	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GCLC—lung cancer	6.4e-06	0.00011	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NCOA3—lung cancer	6.38e-06	0.00011	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.37e-06	0.00011	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTT1—lung cancer	6.32e-06	0.000109	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKR1C1—lung cancer	6.3e-06	0.000109	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.27e-06	0.000108	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.26e-06	0.000108	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GCLC—lung cancer	6.25e-06	0.000108	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP2A6—lung cancer	6.25e-06	0.000108	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ADCY1—lung cancer	6.21e-06	0.000107	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ABCG2—lung cancer	6.21e-06	0.000107	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6.13e-06	0.000106	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—UGT1A1—lung cancer	6.12e-06	0.000105	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ENO2—lung cancer	6.09e-06	0.000105	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HPGDS—lung cancer	6.09e-06	0.000105	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ENO1—lung cancer	6.07e-06	0.000104	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—APOA1—lung cancer	6.05e-06	0.000104	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPP2R1B—lung cancer	6.05e-06	0.000104	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.04e-06	0.000104	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CG—lung cancer	5.97e-06	0.000103	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.97e-06	0.000103	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.97e-06	0.000103	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ENO1—lung cancer	5.92e-06	0.000102	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.92e-06	0.000102	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—RRM1—lung cancer	5.9e-06	0.000102	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA3—lung cancer	5.9e-06	0.000102	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTT1—lung cancer	5.9e-06	0.000102	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GNG11—lung cancer	5.9e-06	0.000102	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.87e-06	0.000101	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GCLC—lung cancer	5.83e-06	0.000101	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP2A6—lung cancer	5.83e-06	0.000101	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.81e-06	0.0001	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—POMC—lung cancer	5.68e-06	9.79e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALDOA—lung cancer	5.62e-06	9.67e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—B4GALT5—lung cancer	5.55e-06	9.56e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.54e-06	9.54e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CREBBP—lung cancer	5.53e-06	9.53e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ENO1—lung cancer	5.53e-06	9.53e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CG—lung cancer	5.53e-06	9.52e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.51e-06	9.49e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NCOA3—lung cancer	5.45e-06	9.39e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP2E1—lung cancer	5.44e-06	9.37e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.44e-06	9.37e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA4—lung cancer	5.4e-06	9.3e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NQO1—lung cancer	5.38e-06	9.27e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.36e-06	9.23e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP2E1—lung cancer	5.31e-06	9.15e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ADCY1—lung cancer	5.3e-06	9.13e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCG2—lung cancer	5.3e-06	9.13e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.27e-06	9.07e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA2—lung cancer	5.26e-06	9.06e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—POMC—lung cancer	5.26e-06	9.06e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NQO1—lung cancer	5.25e-06	9.04e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CD—lung cancer	5.25e-06	9.04e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.22e-06	8.99e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HPGDS—lung cancer	5.2e-06	8.96e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ENO2—lung cancer	5.2e-06	8.96e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ALB—lung cancer	5.18e-06	8.92e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPP2R1B—lung cancer	5.17e-06	8.9e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CREBBP—lung cancer	5.12e-06	8.83e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.1e-06	8.78e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA1—lung cancer	5.08e-06	8.75e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTT1—lung cancer	5.04e-06	8.69e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCC3—lung cancer	5.02e-06	8.65e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.01e-06	8.63e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP2A6—lung cancer	4.99e-06	8.59e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GCLC—lung cancer	4.99e-06	8.59e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.97e-06	8.56e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP2E1—lung cancer	4.96e-06	8.55e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NQO1—lung cancer	4.91e-06	8.45e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKR1C1—lung cancer	4.86e-06	8.38e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CD—lung cancer	4.86e-06	8.37e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—STK11—lung cancer	4.85e-06	8.35e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.8e-06	8.27e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALB—lung cancer	4.8e-06	8.26e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.76e-06	8.2e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—STK11—lung cancer	4.73e-06	8.15e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ENO1—lung cancer	4.73e-06	8.14e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—UGT1A1—lung cancer	4.72e-06	8.13e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.71e-06	8.11e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.65e-06	8.01e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CB—lung cancer	4.57e-06	7.88e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.55e-06	7.84e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GNG11—lung cancer	4.55e-06	7.84e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS2—lung cancer	4.53e-06	7.81e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTP1—lung cancer	4.49e-06	7.73e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—STK11—lung cancer	4.42e-06	7.62e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTP1—lung cancer	4.38e-06	7.54e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CAT—lung cancer	4.37e-06	7.52e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.34e-06	7.48e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALDOA—lung cancer	4.33e-06	7.46e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CAT—lung cancer	4.26e-06	7.34e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ABCB1—lung cancer	4.25e-06	7.32e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP2E1—lung cancer	4.24e-06	7.3e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CB—lung cancer	4.24e-06	7.3e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOA3—lung cancer	4.21e-06	7.25e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS2—lung cancer	4.2e-06	7.23e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NQO1—lung cancer	4.19e-06	7.22e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—TYMS—lung cancer	4.17e-06	7.19e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.15e-06	7.15e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTM1—lung cancer	4.12e-06	7.1e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.1e-06	7.07e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ADCY1—lung cancer	4.09e-06	7.05e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCG2—lung cancer	4.09e-06	7.05e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTP1—lung cancer	4.09e-06	7.05e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—TYMS—lung cancer	4.07e-06	7.01e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.07e-06	7.01e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTM1—lung cancer	4.02e-06	6.93e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ENO2—lung cancer	4.01e-06	6.91e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HPGDS—lung cancer	4.01e-06	6.91e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.99e-06	6.87e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CAT—lung cancer	3.98e-06	6.86e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.96e-06	6.82e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTEN—lung cancer	3.95e-06	6.81e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1A1—lung cancer	3.91e-06	6.73e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTT1—lung cancer	3.89e-06	6.71e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ERCC2—lung cancer	3.88e-06	6.68e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ABCB1—lung cancer	3.87e-06	6.67e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GCLC—lung cancer	3.85e-06	6.63e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2A6—lung cancer	3.85e-06	6.63e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1A1—lung cancer	3.82e-06	6.57e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TYMS—lung cancer	3.8e-06	6.55e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ERCC2—lung cancer	3.78e-06	6.52e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—STK11—lung cancer	3.78e-06	6.51e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—EP300—lung cancer	3.77e-06	6.49e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTM1—lung cancer	3.76e-06	6.48e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTEN—lung cancer	3.66e-06	6.3e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ENO1—lung cancer	3.65e-06	6.28e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1A1—lung cancer	3.56e-06	6.14e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.55e-06	6.11e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ERCC2—lung cancer	3.53e-06	6.09e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTP1—lung cancer	3.5e-06	6.02e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—EP300—lung cancer	3.49e-06	6.01e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CAT—lung cancer	3.4e-06	5.86e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.38e-06	5.83e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—APOA1—lung cancer	3.35e-06	5.78e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCB1—lung cancer	3.31e-06	5.7e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—APOA1—lung cancer	3.27e-06	5.64e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2E1—lung cancer	3.27e-06	5.64e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TYMS—lung cancer	3.25e-06	5.6e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NQO1—lung cancer	3.24e-06	5.57e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTM1—lung cancer	3.21e-06	5.53e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.21e-06	5.53e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CG—lung cancer	3.06e-06	5.27e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—APOA1—lung cancer	3.06e-06	5.27e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP1A1—lung cancer	3.05e-06	5.25e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ERCC2—lung cancer	3.02e-06	5.2e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CG—lung cancer	2.99e-06	5.15e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.93e-06	5.04e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—STK11—lung cancer	2.92e-06	5.02e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—POMC—lung cancer	2.91e-06	5.02e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—POMC—lung cancer	2.84e-06	4.9e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CREBBP—lung cancer	2.84e-06	4.89e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CG—lung cancer	2.79e-06	4.81e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—lung cancer	2.79e-06	4.8e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CREBBP—lung cancer	2.77e-06	4.77e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTP1—lung cancer	2.7e-06	4.65e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CD—lung cancer	2.69e-06	4.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—POMC—lung cancer	2.66e-06	4.58e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALB—lung cancer	2.66e-06	4.58e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CD—lung cancer	2.63e-06	4.53e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CAT—lung cancer	2.63e-06	4.52e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—APOA1—lung cancer	2.61e-06	4.5e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALB—lung cancer	2.59e-06	4.47e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CREBBP—lung cancer	2.59e-06	4.46e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—lung cancer	2.58e-06	4.45e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCB1—lung cancer	2.55e-06	4.4e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TYMS—lung cancer	2.51e-06	4.32e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.5e-06	4.31e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTM1—lung cancer	2.48e-06	4.27e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CD—lung cancer	2.45e-06	4.23e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALB—lung cancer	2.42e-06	4.17e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CG—lung cancer	2.39e-06	4.11e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1A1—lung cancer	2.35e-06	4.05e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CB—lung cancer	2.35e-06	4.04e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ERCC2—lung cancer	2.33e-06	4.02e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS2—lung cancer	2.32e-06	4e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CB—lung cancer	2.29e-06	3.94e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AKT1—lung cancer	2.28e-06	3.92e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—POMC—lung cancer	2.27e-06	3.91e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS2—lung cancer	2.27e-06	3.91e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CREBBP—lung cancer	2.21e-06	3.81e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CB—lung cancer	2.14e-06	3.68e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS2—lung cancer	2.12e-06	3.65e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AKT1—lung cancer	2.11e-06	3.63e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CD—lung cancer	2.1e-06	3.61e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALB—lung cancer	2.07e-06	3.57e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTEN—lung cancer	2.03e-06	3.49e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—APOA1—lung cancer	2.02e-06	3.47e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTEN—lung cancer	1.98e-06	3.41e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—EP300—lung cancer	1.93e-06	3.33e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—EP300—lung cancer	1.89e-06	3.25e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTEN—lung cancer	1.85e-06	3.18e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CG—lung cancer	1.84e-06	3.17e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CB—lung cancer	1.83e-06	3.15e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS2—lung cancer	1.81e-06	3.12e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—EP300—lung cancer	1.76e-06	3.04e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—POMC—lung cancer	1.75e-06	3.02e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CREBBP—lung cancer	1.71e-06	2.94e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CD—lung cancer	1.62e-06	2.79e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALB—lung cancer	1.6e-06	2.75e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTEN—lung cancer	1.58e-06	2.72e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—EP300—lung cancer	1.51e-06	2.59e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—lung cancer	1.43e-06	2.46e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CB—lung cancer	1.41e-06	2.43e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS2—lung cancer	1.4e-06	2.41e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—lung cancer	1.4e-06	2.4e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—lung cancer	1.3e-06	2.25e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTEN—lung cancer	1.22e-06	2.1e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AKT1—lung cancer	1.17e-06	2.01e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—EP300—lung cancer	1.16e-06	2e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AKT1—lung cancer	1.14e-06	1.96e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—lung cancer	1.11e-06	1.92e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AKT1—lung cancer	1.07e-06	1.83e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKT1—lung cancer	9.1e-07	1.57e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—lung cancer	8.6e-07	1.48e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKT1—lung cancer	7.03e-07	1.21e-05	CbGpPWpGaD
